Glycogen synthase kinase (GSK)3 is a ubiquitously expressed serine/threonine kinase existing in two isoforms, namely GSK3a and GSK3b. Aside from the long-recognized role in insulin signal transduction and glycogen biosynthesis, GSK3b has been recently coined as a master control molecule in nuclear factor-kB activation and inflammatory kidney injury. Nevertheless, previous studies are less conclusive because they relied greatly on small molecule inhibitors, which lack selectivity and barely distinguish between the GSK3 isoforms. In addition, early embryonic lethality after global knockout of GSK3b precludes interrogation of the biological role of GSK3b in the adult kidney. To circumvent these issues, the Cre/loxP system was used to generate a conditional knockout mouse model in which the GSK3b gene was specifically deleted in kidney cortical tubules at postnatal mature stage. Kidney-specific ablation of GSK3b resulted in a phenotype no different from control littermates. Knockout mice (KO) were viable and exhibited normal development and normal kidney physiology in terms of kidney function, urine albumin excretion, and urine-concentrating ability. It is noteworthy that apart from normal glomerular and tubulointerstitial morphology, the kidneys from KO demonstrated more glycogen accumulation in the renal cortical tubules as assessed by both periodic acid-Schiff staining for light microscopy and direct biochemical assay, consistent with an elevated glycogen synthetic activity as evidenced by diminished inhibitory phosphorylation of glycogen synthase that occurred subsequent to GSK3b ablation. This finding was further validated by electron microscopic observations of increased deposition of glycogen particles in the renal tubules of KO, suggesting that GSK3a could not fully compensate for the loss of GSK3b in regulating glycogen metabolism in the kidney. Collectively, our study suggests that kidney-specific ablation of GSK3b barely affects kidney function and histology under normal circumstances. Extended examinations of these KO under diseased conditions are merited to understand the role of GSK3b in renal pathophysiology.
Glycogen synthase kinase (GSK)3 is a well-conserved, ubiquitously expressed, and constitutively active serine/ threonine protein kinase, which was originally identified as one that mediates inhibitory phosphorylation of glycogen synthase and either inactivates glycogen synthase or activates ATP-Mg-type 1 protein phosphatase. [1] [2] [3] [4] Interest in GSK3 expanded greatly with the realization that it is a key regulator of cell processes extending well beyond glycogen metabolism to signal transduction, insulin action, gene transcription, protein synthesis, cytoskeletal organization, cell-cycle progression, and development control. 1, 3, 5 In mammalian cells, GSK3 exists as two isoforms, GSK3a (51 kDa) and GSK3b (47 kDa), which are encoded by separate genes that produce highly homologous proteins that differ significantly only in their N-and C-terminal regions. 1 Although displaying 84% structural homology, GSK3a and GSK3b are not functionally interchangeable, and GSK3b possesses unique biological actions. [5] [6] [7] [8] [9] In support of this, mice engineered to lack GSK3b (but still retaining GSK3a) die at mid-gestation because of severe liver degeneration, suggesting that GSK3a and GSK3b have distinct biological roles, as the former is unable to compensate for the loss of the latter. 10 In-depth study showed that GSK3b function is required for the nuclear factor (NF)kB-mediated anti-apoptotic response to tumor necrosis factor. [10] [11] [12] Consistently, recent data have demonstrated that GSK3b is a key regulator of NFkB activity. 11, [13] [14] [15] GSK3b directly binds and phosphorylates NFkB, thereby promoting the transactivation of multiple proinflammatory mediators, including chemokines and adhesion molecules. 16, 17 In patients with inflammatory renal disease, GSK3b was found to be associated with the extent of NFkB activation and the magnitude of inflammatory injury in the diseased kidney. 16 Moreover, selective inhibitors of GSK3b have been lately found to protect from acute kidney injury in animal models. [18] [19] [20] [21] [22] [23] Although GSK3b has been coined as a master control molecule in NFkB activation and inflammatory injury, 10, 11, [13] [14] [15] 17, 24 most of the previous findings were based on small molecule inhibitors of GSK3, which are unable to discriminate between GSK3a and GSK3b; 19, 20, 25 thus, it is not possible to precisely evaluate the role of GSK3b in the pathogenesis of renal inflammation using these drugs. Genetic disruption of GSK3b would be more selective; however, mice with global GSK3b knockout die in embryo stages because of massive hepatic necrosis. 10 Therefore, to circumvent this early embryonic lethality, it is imperative to establish a mouse model in which the kidney-specific expression of GSK3b is specifically deleted. Moreover, considering that GSK3b and its related signaling pathways are indispensable for embryonic kidney development, 26 kidneyspecific ablation of GSK3b at postnatal stage will be an ideal approach to avoid potential congenital defects of the kidney.
In this study, we used the Cre/loxP gene targeting system 27 and generated conditional knockout mice (KO) in which the GSK3b gene was specifically disrupted in the kidney cortical tubular epithelium at postnatal maturity stage. Mice with kidney-specific knockout of GSK3b are generally healthy with normal kidney physiology and histology, except evident glycogen accumulation in tubular epithelial cells as compared with control littermates. This novel transgenic mouse model might serve as an invaluable tool to understand the role of GSK3b in kidney physiology and pathology.
MATERIALS AND METHODS
Generation of Kidney Tubular-Specific GSK3b KO and Genotyping Animal experimental studies were approved by the institution's Animal Care and Use Committee and they conform to the USDA regulations and the NIH guidelines for humane care and use of laboratory animals. Mice (C57BL/6J strain) with the floxed GSK3b gene were obtained from Dr James Woodgett (Samuel Lunenfeld Research Institute of Mount Sinai Hospital, Toronto, Canada). 8 These mice carry two loxp loci flanking exon 2, allowing excision of exon 2 and disruption of the GSK3b gene in the presence of Cre recombinase. These 'floxed' mice appear phenotypically identical to wild-type mice with normal physiological and functional activities. Transgenic mice expressing Cre recombinase under the control of a g-glutamyltranspeptidase (gGT) promoter were obtained from Dr Eric Neilson (Venderbilt University, Nashville, TN, USA). 28 By mating GSK3b-floxed mice with gGT.Cre transgenic mice, mice that were heterozygous for the GSK3b-floxed allele were generated (genotype: GSK3b fl/ þ , Cre). These mice were crossbred to generate the desired knockout offspring that were homozygous for the GSK3b-floxed allele and carried the Cre allele (genotype: GSK3b fl/fl , Cre). The breeding protocol also generated heterozygous littermates (genotype: GSK3b fl/ þ , Cre) as well as wild-type and several control groups (Ctrl) with different genotypes (GSK3b 0 was used to genotype solid organs, such as the heart, liver, and kidney, and yielded 1095, 886, and 209 bp bands, respectively, for the floxed, wild-type, and excised alleles. Transgenic mice were born normally at the expected Mendelian distribution. In all experiments, littermates from the same breeding pairs were used as controls.
Blood Pressure Measurement
Just before death, mice were anesthetized and prepared for a measurement of mean arterial pressure (MAP). A polyethylene catheter was inserted into the femoral artery. After a 15-min equilibration period, a computer running WINDAS software (DATAQ Instruments, Akron, OH, USA) continuously monitored and documented the steady mean arterial blood pressure using a pressure transducer.
RNA Extraction and Real-Time Reverse
Transcription-PCR Total RNA was extracted from indicated animal tissues using TRIzol solution (Invitrogen, Carlsbad, CA, USA) according to the instructions specified by the manufacturer. RNA was then diluted to 3 mg/ml in RNase-free distilled water. Firststrand cDNA was prepared using 3 mg RNA, Superscript RT reverse transcriptase (Invitrogen), and oligo (dT) primer according to the manufacturer's instructions. Quantitative real-time PCR was carried out on a Stratagene Mx4000 multiplex quantitative PCR system (Stratagene, La Jolla, CA, USA) using primers specific for murine GSK3b, forward: GACGAACAT-3 0 . All reactions were performed in triplicate using Brilliant SYBR Green QPCR Master Mix (Stratagene). Fluorescence values of SYBR Green I dye, representing the amount of product amplified at that point in the reaction, were recorded in real time at both the annealing step and the extension step of each cycle. The C t value, defined as the point at which the fluorescence signal was statistically significant above background, was calculated for each amplicon in each experimental sample using the Stratagene Mx4000 software. This value was then used to determine the relative amount of amplification in each sample by interpolating from the standard curve. The transcript level of GSK3b was normalized to GAPDH amplification.
SDS-PAGE and Western Immunoblot Analysis
Animal tissues were homogenized in RIPA buffer supplemented with protease inhibitors (1% Nonidet P-40, 0.1% SDS, 100 mg/ml phenylmethysulfonyl fluoride, 0.5% sodium deoxycholate, 1 mM sodium orthovanadate, 2 mg/ml aprotin, 2 mg/ml leupeptin, 5 mM EDTA in PBS). Protein concentration was determined using a bicinchoninic acid protein assay kit (Sigma, St Louis, MO, USA). Samples with equal amounts of total protein (50 mg) were fractionated by 7.5-15% SDSpolyacrylamide gels under reducing conditions and analyzed by western immunoblot as described previously. 29 The polycolonal antibodies against actin, GSK3b, WT1, and podocin was purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA) and those for nephrin were acquired from Progen (Heidelberg, Germany). The monocolonal antibody against GSK3b was purchased from Cell Signaling Technology (Beverly, MA, USA). To discern the protein compositions of urine, equal amount of urine samples were subjected to SDS-PAGE, followed by Coomassie blue staining.
Biochemical Analysis of Urine and Serum
Urine albumin was measured using a mouse Albumin ELISA quantitation kit, according to the manufacturer's protocol (Bethyl Laboratories, Montgomery, TX, USA). Serum and urine creatinine and blood urea nitrogen (BUN) were determined by a routine procedure as described previously. 30 
Glomerular Isolation
Glomerular isolation was carried out according to the method described elsewhere. 31 In brief, mice were anesthetized and perfused by infusing the abdominal artery with 5 ml of PBS containing 8 Â 10
7 Dynabeads M-450 (Dynal Biotech ASA, Oslo, Norway). After perfusion, the kidneys were removed and cut into 1-mm 3 pieces and digested in collagenase A (1 mg/ml) at 371C for 30 min with gentle shaking. The tissue was then pressed gently through a 100-mm cell strainer (BD Falcon, Bedford, MA, USA). The glomeruli containing Dynabeads were then gathered using a magnetic particle concentrator. The isolated glomeruli were washed three times with cold PBS and used for subsequent studies.
Morphological Studies
Formalin-fixed kidneys were embedded in paraffin and prepared in 3 mm-thick sections. For general histology, sections were processed for hematoxylin and eosin (H&E) staining and periodic acid-Schiff (PAS) staining. Morphology of all sections was assessed by a single observer in a blinded manner.
Immunofluorescent staining
Indirect immunofluorescent staining of GSK3b was carried out on frozen kidney sections using rabbit monoclonal anti-GSK3b antibody (Cell Signaling Technology). The Alexa Fluor goat anti-rabbit IgG (Molecular Probes, Eugene, OR, USA) was used as secondary antibody. As a negative control, the primary antibody was replaced by nonimmune serum from the same species; no staining occurred. Immunofluorescent staining of podocin, nephrin, and WT1 was performed in a similar manner using respective antibodies. For fluorescence microscopy, all sections were stained and analyzed at the same time to exclude artifacts due to variable decay of the fluorochrome. 29 Sections were examined using a Nikon Microphot-FX fluorescence microscope equipped with a Spot II digital camera.
Computerized morphometry
Fluorescent immunohistochemistry images were captured and digitized using a computerized image analysis system consisting of a high-resolution charge-coupled device digital camera attached to a fluorescent microscope (Olympus BX41, Japan) and to a computer. Images were displayed at a pixel resolution of 1024 Â 768 pixels (spatial resolution ¼ 0.11 mm per pixel). The Image Pro Plus version 5.1 software (MediaCybernetics, MD, USA) was used for image segmentation, threshold establishment, and signal intensity measurements. Manual corrections were performed as required. Overall, 40 glomeruli were sampled for morphometric analysis and final data were expressed as the value of integrated pixel density relative to the control group.
Transmission electron microscopy
For transmission electron microscopy, the kidney was cut into small pieces (o1 mm 2 ), fixed with 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer, pH 7.4, postfixed with 1% (wt/vol) osmium tetroxide, and embedded in Epon 812 (Polysciences, Warrington, PA, USA). Conventional electron micrographs were obtained using a Zeiss EM-10 microscope operated at 60 kV and absolute magnifications of 63 000 or 80 000. Absolute counting of total measurable glycogen particles was performed in 10 random electron microscopy fields of tubules per mouse in 6 mice per group.
Determination of Glycogen Content
Kidney tissues were collected, cut, weighed, and made soluble by boiling for 30 min in 30% potassium hydroxide saturated with sodium sulfate. Once tissues were completely digested, glycogen was precipitated with 95% ice-cold ethanol and incubated on ice for 20 min. Samples were spun for 30 min at 500 g. The pellets were resuspended in 1 ml distilled water and 1 ml 5% phenol was added. A colorimetric reaction was obtained by adding 5 ml of sulfuric acid. After incubation on ice for 30 min, absorbance was determined at a wavelength of 490 nm. Contents of glycogen in tissue samples were determined from glycogen standards (Sigma) run with each assay and normalized to tissue weight of each individual sample. Final results were expressed as microgram of collagen per milligram of kidney. Glycogen was also visualized in paraffin-embedded tissue sections by PAS staining for light microscopy.
Statistics
For immunoblot analysis, bands were scanned and the integrated pixel density was determined using a densitometer and the National Institutes of Health image analysis program. All data are expressed as mean ± s.d. Statistical analysis of the data from multiple groups was performed by ANOVA, followed by Student-Newman-Keuls tests. Data from two groups were compared by t-test. Po0.05 was considered significant.
RESULTS

Breeding Strategy to Target the GSK3b Gene in the Kidney
Using the Cre/loxP-mediated recombination strategy (Figure 1a) , a conditional knockout mouse model, in which the GSK3b gene was specifically deleted in renal tubular epithelial cells was created on the C57BL/6 background. The structure of the loxP-flanked (floxed) GSK3b allele is shown in Figure 1a . LoxP sites were inserted to flank exon 2 at the GSK3b locus through homologous recombination in embryonic stem cells, as described previously. By crossing GSK3b-floxed mice with gGT.Cre transgenic mice in which Cre recombinase was driven under the gGT promoter, mice heterozygous for the GSK3b-floxed allele were generated (genotype: GSK3b fl/ þ , Cre) ( Figure 1b ). These mice were further crossbred to inactivate both GSK3b alleles by Cremediated excision, thereby creating conditional KO in which the GSK3b gene was specifically disrupted in the kidney cortical tubular epithelium (genotype: GSK3b fl/fl , Cre). The breeding protocol also generated heterozygous littermates (genotype: GSK3b fl/ þ , Cre) as well as wild-type and several control groups (Ctrl) with different genotype (GSK3b þ / þ ; Figure 2b ) of the kidney from KO were also normal as compared with that from control littermates. To examine the efficiency and specificity of GSK3b conditional knockout, message RNA expression levels of GSK3b were evaluated by quantitative real-time reverse transcriptase (RT)-PCR analysis on RNA extracted from different tissues from KO and control mice. The expression of GSK3b mRNA was barely affected in any other extrarenal organs, including the liver, heart, and skeletal muscle, but significantly diminished in the KO kidney to B30% of the level in the control kidney ( Figure 2c ). Next, to confirm the specificity of recombination of the GSK3b-floxed allele mediated by Cre excision, PCR analysis was carried out on genomic DNA extracted from the kidney and extrarenal organs. As shown in Figure 2d , the excised GSK3b allele was evidently detected (209-bp band) only in the kidney from KO mice, but not in the kidney from control littermates. In addition, excision of the floxed GSK3b allele only occurred in the kidney, but not in other tissues, such as the heart, skeletal muscle, or liver (data not shown) from KO mice. No tissues from control littermates exhibited a Cre-mediated recombination. It is noteworthy that in PCR amplicons derived from the kidney of KO mice, a very faint 1095-bp band corresponding to the floxed GSK3b allele was still observable (Figure 2d Message RNA expression levels of GSK3b in different organs were evaluated by quantitative real-time RT-PCR analysis, normalized to GAPDH amplification, and expressed as ratios between GSK3b and GAPDH mRNA levels relative to those in the same organs from Ctrl mice; *Po0.01 versus Ctrl kidney (n ¼ 6). (d) The GSK3b gene was largely deleted by Cre-mediated excision only in the kidney of KO mice (genotype: fl/fl, Cre), but was barely affected either in other extrarenal organs, such as the heart of the KO mice or in any organs of Ctrl mice (genotype: þ / þ , Cre; or fl/fl). PCR analysis of exon 2 of the GSK3b gene and the Cre gene was carried out on genomic DNA extracted from the kidney or other extrarenal organs, such as the heart. The PCR bands of wild-type (886 bp) and floxed (1095 bp) GSK3b allele and excised (209 bp) fragment, and Cre (411 bp) allele are indicated. (e) Protein expression of GSK3b was successfully ablated only in the kidney of KO mice (genotype: fl/fl, Cre), but was affected neither in other extrarenal organs, such as the heart of the KO mice, nor in any organs of littermate controls (genotype: þ / þ , Cre; or fl/fl; or fl/ þ , cre). As control, renal expression of GSK3b was barely affected in KO mice, denoting a highly isoform-specific targeting of GSK3 in the kidney. (f) The temporally controlled inactivation of renal expression of GSK3b was associated with regulated expression of gGT and Cre. Immunoblot analysis of GSK3b, gGT, Cre, and actin was carried out on kidney homogenates derived from KO (genotype: fl/fl, Cre) or Ctrl (genotype: fl/fl) mice. To confirm the specificity of the monoclonal anti-GSK3b antibody used to probe the blot, a recombinant standard GSK3b was loaded and analyzed simultaneously. Std.: recombinant standard GSK3b. (g) Ablation of GSK3b was restricted to renal tubules. Kidney cryosections derived from KO or Ctrl mice were subjected to fluorescent immunohistochemistry staining of GSK3b (red color) by applying the monoclonal anti-GSK3b antibody used in panel f and counterstained with 4 0 ,6-diamidino-2-phenylindole (DAPI, blue color). White dotted lines highlight glomeruli. Scale bar ¼ 20 mm.
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Under basal conditions, GSK3b is constitutively expressed in adult mice in different organs, including the kidney, heart (Figure 2e ), skeletal muscle, and liver (data not shown). Inactivation of the GSK3b gene by Cre-mediated excision resulted in a reduction of the expression of the GSK3b protein only in the kidneys from KO mice. Western blot analysis demonstrated that expression level of the GSK3b protein in the kidneys was drastically reduced in KO mice, compared with controls (Figure 2e) . No change in GSK3b protein expression was noted in other organs from KO mice or in any organs from control littermates. In contrast to diminished GSK3b expression in the kidneys from KO mice, expression of the GSK3a isoform was barely affected, confirming a highly isoform-specific and spatially restricted gene targeting (Figure 2e) .
As the expression of Cre recombinase was under the control of the gGT promoter, which becomes active in the kidney cortical tubular epithelium only in late kidney development stage, beginning around postpartum day 14 when nephrogenesis is virtually complete. 28, 32 To discern the temporally controlled ablation of GSK3b mediated by Cre in the kidney from KO mice, a time course examination of GSK3b expression in the KO kidney was carried out. As shown in Figure 2f , gGT was barely detected in both KO and Ctrl kidneys before 4 weeks after birth but was evidently induced and persistently expressed thereafter. Congruent with this, KO mice started to express Cre in the kidney after 4 weeks of age. Reciprocally, GSK3b was constitutively expressed in the kidney in the first 2 postpartum weeks but was later progressively and rapidly ablated, in agreement with gGTdependent Cre expression and Cre-mediated excision of the GSK3b gene (Figure 2f ). In contrast, in the kidneys from control littermates (Ctrl), Cre expression was constantly absent and no significant changes to GSK3b expression were noted (Figure 2f) . Furthermore, immunofluorescent staining demonstrated that GSK3b was basally and ubiquitously expressed in the glomeruli and tubules in kidney tissues from control littermates (Figure 2g ). By contrast, in KO mice, a nearly complete elimination of GSK3b expression was observed in tubules, whereas glomerular expression was barely affected, denoting a tubular-specific knockout of GSK3b (Figure 2g) . To confirm the specificity of the monoclonal antibody used for fluorescent immunohistochemistry staining, immunoblots of kidney homogenates probed by this antibody displayed a highly specific single target band of GSK3b as identified by a standard control of recombinant GSK3b (Figure 2f ).
Renal Physiology of Adult Mice with Kidney-Specific Ablation of GSK3b
To estimate renal physiology, various kidney functional and biochemical parameters were assessed. As shown in Figure 3 , KO mice and control littermates had equal serum creatinine levels ( Figure 3a ) and BUN levels (Figure 3b ), implying that Figure 3 Kidney-specific conditional knockout of GSK3b in mice does not affect renal physiological function. Ten-week old mice were kept in metabolic cages and urine and blood samples were collected. Biochemistry analyses were carried out to determine (a) serum creatinine levels, (b) blood urea nitrogen levels, (c) serum potassium, sodium, chloride, and bicarbonate levels, (d) 24 h urine volume, (g) urinary albumin to creatinine ratios, (h) urinary sodium and potassium levels; besides, animals were subjected to water deprivation for 24 h, followed by (e) urine osmolality assay and (f) measurement of body weight loss; KO versus Ctrl not significant (n ¼ 6).
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Y Ge et al mice had normal kidney function after kidney-specific GSK3b knockout. Analysis of serum electrolytes revealed similar levels of sodium, potassium, chloride, and bicarbonate in KO and control mice (Figure 3c ), excluding the possibility that GSK3b knockout induces tubular dysfunction and causes renal tubular acidosis. This is further supported by normal and comparable urine volume (Figure 3d) , urine albumin to creatinine ratio (Figure 3g) , and urinary sodium and potassium concentrations (Figure 3h ) observed from the KO and Ctrl groups. In addition, urinary dipsticks were applied and demonstrated that urine samples from Ctrl and KO mice had comparable and normal pH (B6) and were negative for glucose. Upon water restriction for 24 h, KO mice and control littermates had comparable urine osmolality measured before or after water restriction (Figure 3e) , as well as similar body weight loss (Figure 3f) , suggesting a normal tubular function after GSK3b inactivation. Moreover, MAP was measured before mice were killed and the MAP was 78.7 ± 8.1 mm Hg for control littermates and 81.7 ± 7.6 mm Hg for KO mice (n ¼ 6; P ¼ 0.52), denoting that KO and Ctrl mice had comparable blood pressure. Collectively, these data suggest that postnatal knockout of GSK3b in the kidney does not affect renal physiological function under normal conditions.
Renal Histology of Mice with Kidney-Specific Ablation of GSK3b
Under normal conditions, KO mice and control littermates excreted equal and scarce amounts of low-molecular-weight proteins in urine, which are consistent with small-sized proteins normally secreted by the tubular epithelium; no albumin or higher-molecular-weight proteins were observed in both control and KO mice at different ages as indicated (Figure 4a ), suggesting that KO mice are less likely to have glomerular sieving defect. In support of this, the kidneys from KO mice showed a normal glomerular morphology under H&E staining (Figure 4b ). This was further corroborated by immunofluorescent microscopic observations of equal expression and normal distribution of major slit diaphragm-associated proteins, including nephrin, podocin, and the podocyte-specific differentiation marker, WT1, in the glomeruli of the kidney from KO as compared with control littermates (Figure 4b ). Fluorescent microscopic observations were revalidated by computerized morphometric analysis, again showing comparable staining intensity of various podocyte markers in the kidneys from both KO and control mice (Figure 4c ). Immunoblot analysis of the glomeruli isolated from KO and Ctrl mice confirmed the morphology findings and showed equal expression of podocin, nephrin, and WT1 as referred to actin (Figure 4d) . Moreover, electron microscopy demonstrated a normal glomerular morphology with an intact and normal ultrastructure of podocyte foot processes, slit diaphragms, glomerular base membrane, and glomerular capillary and mesangial area (Figure 4e ).
The kidneys from KO mice also showed normal tubulointerstitium and vasculatures under H&E staining as compared with those from control littermates (Figure 5a ). It is noteworthy that tubules in the KO kidneys demonstrated more intense PAS staining than did those from the Ctrl kidneys, mainly located in the brush border of the tubules (Figure 5a) , denoting an elevated glycogen synthetic activity in the KO kidney. In consistence with this finding, immunoblot analysis of kidney homogenates indicated that inhibitory phosphorylation of glycogen synthase was substantially diminished, subsequent to GSK3b ablation in the KO kidneys (Figure 5b) . Furthermore, biochemical quantification of glycogen with an acid hydrolysis technique applied to fresh kidney samples independently demonstrated significantly more glycogen content in the KO kidney (Figure 5c ), confirming the morphology findings on PAS staining. Electron microscopy reveals normal morphology and quantity of subcellular organelles, including the nucleus, mitochondria, endoplasmic reticulum, and Golgi complex in proximal tubules. Notably, compared with the control group ( Figure 6A , A 0 ), tubules in the KO kidney ( Figure 6B , B 0 ) contained prominently more glycogen particles under ultrastructural analysis, which appeared as electron-dense particles ranging in size from 20 to 25 nm in diameter and closely associated with tubules of the smooth endoplasmic reticulum. Absolute counting of glycogen particles corroborated the electron microscopic observations and showed that the amount of total measurable glycogen was markedly increased in KO mice.
DISCUSSION
GSK3 is a ubiquitously expressed serine/threonine kinase encoded by two isoforms, namely GSK3a and GSK3b. In cell signaling networks, GSK3 resides at the nexus of multiple pathways, including insulin signaling pathway, canonical wingless (Wnt) pathway, 33 NFkB, [13] [14] [15] 24 and NF-AT 3 pathway. Besides glycogen synthase, GSK3 has been shown to phosphorylate a number of other substrates, such as the microtubule-associated protein tau, adenomatous polyposis coli, and various transcription factors, including b-catenin, NF-AT, NFkB, c-Myc, c-Jun, and c-Myb. 2, 3, 9 Initially identified as a regulator of glycogen biosynthesis, GSK3 is now known to be a key regulator of a large number of cellular processes and has been implicated in diverse diseases including diabetes, Alzheimer's disease, stroke, and inflammatory diseases. 19, 20, 25, 34 In the kidney, expression of GSK3b is low under physiological conditions, but is prominently induced in the tubular epithelia upon disease state, including lupus nephritis, acute cellular rejection of the allograft kidney, and chronic renal allograft disease. 16, 18 Although the increased GSK3b expression was found to highly correlate with the extent of kidney injury, 16 whether this elevated expression of GSK3b is a selfprotective mechanism or an event that mediates kidney injury is largely unknown. To address this issue, recent studies have used the highly selective small molecule inhibitors of GSK3. In rats with acute endotoxemia, specific GSK3 inhibitors suppressed NFkB activation, ameliorated systemic inflammatory responses, and reduced injury in multiple organs, including the kidney. 23, 35 Moreover, in mice stimulated with lipopolysaccharide, Martin et al 21 demonstrated
that GSK3 inhibition attenuated proinflammatory cytokines (IL-12, IL-6, and IFN-g), enhanced production of the antiinflammatory cytokine IL-10, and improved kidney injury and general survival. 22 All these findings suggest that GSK3 has a detrimental role in kidney injury and that the suppression of GSK3 is renoprotective. However, the effect of Ablation of GSK3b in renal tubules Y Ge et al administration of small molecule chemical compounds is not kidney specific but systemic, and might have a general protective effect as evidenced by the diminished levels of circulating cytokines in treated animals, 21, 22 which could have a secondary beneficial action on injuries to every organ systems, including the kidney. Therefore, whether induced GSK3b expression in the kidney mediates the injury and whether inhibition of GSK3b in the kidney is directly renoprotective still remains uncertain. In addition, a major pitfall of using these small molecule chemical compounds is that even the newly discovered novel inhibitors, which have been claimed to have very high selectivity on GSK3, actually still have some nonspecific inhibitory effects on other cell signaling transducers including the cyclin-dependent kinase, 18 which also has a critical role in regulating cell cycles, inflammatory response, and immune reaction. Therefore, whether the renoprotective action is actually attributable to GSK3b inhibition or due to an unspecific effect on other signaling transducers is uncertain. Moreover, so far, no chemical inhibitors have been found to only inhibit GSK3b but barely affect GSK3a. 20, 25 Thus, the arbitrary conclusion that renoprotection by these small molecule inhibitors is due to suppression of the activity of the b-isoform of GSK3 is doubtful and unwarranted, and the exact role of GSK3b in the pathogenesis of kidney disease is still obscure.
To address these unresolved issues, genetic knockout of GSK3b would be instrumental and highly selective. However, GSK3b is ubiquitously expressed and critical for embryonic development and traditional global knockout of GSK3b is lethal; mice die during the embryo stage because of severe hepatic necrosis and massive hepatocyte apoptosis, 10 thus making it impossible to obtain adult animals to set up models of kidney disease for studying the effects of GSK3b. Hence, a kidney-specific conditional knockout of GSK3b is imperative to decipher the role of GSK3b in kidney physiology and pathology. The Cre/loxP gene targeting system is a powerful and versatile tool for examining tissue-specific gene function in vivo that cannot be investigated by conventional knockout due to embryonic lethality. 27 In the Cre/loxP system, genomic excision of the loxP-tagged gene is controlled by Cre recombinase and only occurs in Cre-expressing tissues. 27 By far, multiple mouse strains have been created to express Cre exclusively in the kidney under the control of promoters of kidney-specific molecules. Unfortunately, most of these mice start to express Cre in kidney cells as early as in the embryo stage. 27 As mentioned above, GSK3b is critically important for signaling pathways controlling embryo development, like the Wnt pathway, 33 in many organ systems, including the kidney. 26 Therefore, ablation of GSK3b using these Cre-expressing mice would possibly induce defects in embryo kidney development. The transgenic mice used in this study express Cre recombinase under the control of a gGT promoter and produce Cre recombinance only in the kidney cortical tubular epithelium, Ablation of GSK3b in renal tubules Y Ge et al but not in other tissues, including the brain, liver, spleen, skeletal muscle, lung, bone marrow, or adrenal gland. 28 Importantly, gGT promoter-governed Cre expression occurs in the late stage of kidney development, beginning around postpartum day 14 when nephrogenesis is virtually complete. 28, 32 Consistently, in our mice with GSK3b ablation, no notable defects were observed in the kidney either morphologically or functionally, suggesting that postnatal disruption of GSK3b is less likely to cause developmental abnormality. In addition, glomerular and tubulointerstitial histology reveals normal kidney structures in KO that are basically no different from control littermates. One potential limitation of our study is that GSK3b was ablated in only one portion of the renal epithelia and no other renal cell lineages were impacted and this might result in no renal phenotype. In-depth studies to knockout GSK3b in other nephron segments are merited to verify our observations and to define the exact role of GSK3b in nephrobiology.
The current understanding of the impact of GSK3b inhibition in vivo on kidney physiology are mainly based on the studies of lithium, an antipsychotic and antimanic drug 36 that has been lately demonstrated to have potent GSK3 inhibitory activity. 37, 38 Lithium has been widely used as a mood stabilizer for decades in patients with psychiatric diseases, including mania, depression, and bipolar affective disorder. 36 Side effects have been occasionally reported, including vasopressin-resistant nephrogenic diabetes insipidus, increased urinary sodium loss, and renal tubular acidosis. 36, [39] [40] [41] [42] Moreover, chronic lithium treatment is associated with chronic interstitial nephritis and a major cellular reorganization of the collecting duct cells with a marked increase in the fraction of intercalated cells and a significant decrease in the fraction of principal cells. 41, 42 However, these findings might be flawed because healthy subjects were used as controls and chronic renal lesions were also found in psychiatric patients not treated with lithium, suggesting that chronic interstitial nephritis may be associated with psychiatric disorders per se and not with lithium treatment. 39, 40 Nevertheless, lesions such as cytoplasmic swelling with dilated tubules and glycogen accumulation in renal tubules have been consistently noted in lithium-treated patients but not found in psychiatric controls. 41, 43 Despite these longrecognized side effects of lithium on renal physiology, the molecular mechanisms and responsible drug targets remain highly illusive. One explanation is that lithium may obliterate cyclic adenosine monophosphate signaling pathways that are important in the maintenance of kidney architecture and physiological homeostasis, such as regulation of water balance. 41, 42 Besides, recently, lithium has been postulated to induce renal physiology changes by GSK3 inhibition. [37] [38] [39] However, owing to the drawbacks of the poor selectivity of lithium, inhibition of which GSK3 isoform accounts for the renal effects is not clear, and conditional KO generated in this study will be instrumental in deciphering this issue. As a matter of fact, although kidney-specific GSK3b KO did not show any notable difference from littermate controls in terms of kidney function, proteinuria, urine-concentrating ability, as well as glomerular and tubulointerstital histology, more glycogen deposition was found in the tubules as evidenced by PAS staining and under ultrastructure examination as well, congruent with the findings in lithium-treated patients. 40, 43 Accordingly, extended observations of these mice under normal or diseased conditions are warranted to understand the role of GSK3b in lithium-induced histological and functional changes of the kidney.
In conclusion, we have successfully established a conditional knockout mouse model with kidney-specific ablation of GSK3b at postnatal mature stage. The mice had a phenotype no different from control littermates, except they had more glycogen accumulation in renal cortical tubules, supporting that GSK3a could not fully compensate for the loss of GSK3b in this regard. Our findings provide new insights into the functional role of GSK3b in kidney biology and in the maintenance of kidney homeostasis. This transgenic mouse model would be instrumental in deciphering the exact role of GSK3b in kidney physiology and pathology.
